Literature DB >> 33452267

The challenges of containing SARS-CoV-2 via test-trace-and-isolate.

Sebastian Contreras1,2, Jonas Dehning1, Matthias Loidolt1, Johannes Zierenberg1, F Paul Spitzner1, Jorge H Urrea-Quintero1, Sebastian B Mohr1, Michael Wilczek1,3, Michael Wibral4, Viola Priesemann5,6.   

Abstract

Without a cure, vaccine, or proven long-term immunity against SARS-CoV-2, test-trace-and-isolate (TTI) strategies present a promising tool to contain its spread. For any TTI strategy, however, mitigation is challenged by pre- and asymptomatic transmission, TTI-avoiders, and undetected spreaders, which strongly contribute to "hidden" pan class="Disease">infection chains. Here, we study a semi-analytical model and identify two tipping points between controlled and uncontrolled spread: (1) the behavior-driven reproduction number [Formula: see text] of the hidden chains becomes too large to be compensated by the TTI capabilities, and (2) the number of new infections exceeds the tracing capacity. Both trigger a self-accelerating spread. We investigate how these tipping points depend on challenges like limited cooperation, missing contacts, and imperfect isolation. Our results suggest that TTI alone is insufficient to contain an otherwise unhindered spread of SARS-CoV-2, implying that complementary measures like social distancing and improved hygiene remain necessary.

Entities:  

Year:  2021        PMID: 33452267     DOI: 10.1038/s41467-020-20699-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  14 in total

1.  An immunization model for a heterogeneous population.

Authors:  H W Hethcote
Journal:  Theor Popul Biol       Date:  1978-12       Impact factor: 1.570

2.  Interrupting transmission of COVID-19: lessons from containment efforts in Singapore.

Authors:  Vernon J Lee; Calvin J Chiew; Wei Xin Khong
Journal:  J Travel Med       Date:  2020-05-18       Impact factor: 8.490

3.  Modeling human mobility responses to the large-scale spreading of infectious diseases.

Authors:  Sandro Meloni; Nicola Perra; Alex Arenas; Sergio Gómez; Yamir Moreno; Alessandro Vespignani
Journal:  Sci Rep       Date:  2011-08-12       Impact factor: 4.379

4.  Economic and social consequences of human mobility restrictions under COVID-19.

Authors:  Giovanni Bonaccorsi; Francesco Pierri; Matteo Cinelli; Andrea Flori; Alessandro Galeazzi; Francesco Porcelli; Ana Lucia Schmidt; Carlo Michele Valensise; Antonio Scala; Walter Quattrociocchi; Fabio Pammolli
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-18       Impact factor: 11.205

5.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

6.  Estimate of the Basic Reproduction Number for COVID-19: A Systematic Review and Meta-analysis.

Authors:  Yousef Alimohamadi; Maryam Taghdir; Mojtaba Sepandi
Journal:  J Prev Med Public Health       Date:  2020-03-20

7.  South Korea's responses to stop the COVID-19 pandemic.

Authors:  JaHyun Kang; Yun Young Jang; JinHwa Kim; Si-Hyeon Han; Ki Rog Lee; Mukju Kim; Joong Sik Eom
Journal:  Am J Infect Control       Date:  2020-06-06       Impact factor: 2.918

8.  Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.

Authors:  Rachael Pung; Calvin J Chiew; Barnaby E Young; Sarah Chin; Mark I-C Chen; Hannah E Clapham; Alex R Cook; Sebastian Maurer-Stroh; Matthias P H S Toh; Cuiqin Poh; Mabel Low; Joshua Lum; Valerie T J Koh; Tze M Mak; Lin Cui; Raymond V T P Lin; Derrick Heng; Yee-Sin Leo; David C Lye; Vernon J M Lee
Journal:  Lancet       Date:  2020-03-17       Impact factor: 79.321

Review 9.  Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.

Authors:  Chih-Cheng Lai; Yen Hung Liu; Cheng-Yi Wang; Ya-Hui Wang; Shun-Chung Hsueh; Muh-Yen Yen; Wen-Chien Ko; Po-Ren Hsueh
Journal:  J Microbiol Immunol Infect       Date:  2020-03-04       Impact factor: 4.399

10.  Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.

Authors:  Feng Ye; Shicai Xu; Zhihua Rong; Ronghua Xu; Xiaowei Liu; Pingfu Deng; Hai Liu; Xuejun Xu
Journal:  Int J Infect Dis       Date:  2020-04-02       Impact factor: 3.623

View more
  38 in total

Review 1.  Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy.

Authors:  Zhaomin Feng; Yi Zhang; Yang Pan; Daitao Zhang; Lei Zhang; Quanyi Wang
Journal:  Med Rev (Berl)       Date:  2022-04-28

2.  Unravelling the dynamics of the COVID-19 pandemic with the effect of vaccination, vertical transmission and hospitalization.

Authors:  Rubayyi T Alqahtani; Salihu S Musa; Abdullahi Yusuf
Journal:  Results Phys       Date:  2022-06-14       Impact factor: 4.565

3.  Epidemic management and control through risk-dependent individual contact interventions.

Authors:  Tapio Schneider; Oliver R A Dunbar; Jinlong Wu; Lucas Böttcher; Dmitry Burov; Alfredo Garbuno-Inigo; Gregory L Wagner; Sen Pei; Chiara Daraio; Raffaele Ferrari; Jeffrey Shaman
Journal:  PLoS Comput Biol       Date:  2022-06-23       Impact factor: 4.779

4.  When might host heterogeneity drive the evolution of asymptomatic, pandemic coronaviruses?

Authors:  Kenichi W Okamoto; Virakbott Ong; Robert Wallace; Rodrick Wallace; Luis Fernando Chaves
Journal:  Nonlinear Dyn       Date:  2022-06-20       Impact factor: 5.741

5.  Mutation induced infection waves in diseases like COVID-19.

Authors:  Fabian Jan Schwarzendahl; Jens Grauer; Benno Liebchen; Hartmut Löwen
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

6.  Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic.

Authors:  Yuki Furuse
Journal:  Int J Environ Res Public Health       Date:  2022-04-19       Impact factor: 4.614

7.  Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states.

Authors:  Fuqing Wu; Amy Xiao; Jianbo Zhang; Katya Moniz; Noriko Endo; Federica Armas; Mary Bushman; Peter R Chai; Claire Duvallet; Timothy B Erickson; Katelyn Foppe; Newsha Ghaeli; Xiaoqiong Gu; William P Hanage; Katherine H Huang; Wei Lin Lee; Mariana Matus; Kyle A McElroy; Steven F Rhode; Stefan Wuertz; Janelle Thompson; Eric J Alm
Journal:  medRxiv       Date:  2021-03-14

8.  A spatio-temporal model based on discrete latent variables for the analysis of COVID-19 incidence.

Authors:  Francesco Bartolucci; Alessio Farcomeni
Journal:  Spat Stat       Date:  2021-03-27

9.  On the heterogeneous spread of COVID-19 in Chile.

Authors:  Danton Freire-Flores; Nyna Llanovarced-Kawles; Anamaria Sanchez-Daza; Álvaro Olivera-Nappa
Journal:  Chaos Solitons Fractals       Date:  2021-06-12       Impact factor: 5.944

Review 10.  A look into the future of the COVID-19 pandemic in Europe: an expert consultation.

Authors:  Emil Nafis Iftekhar; Viola Priesemann; Rudi Balling; Simon Bauer; Philippe Beutels; André Calero Valdez; Sarah Cuschieri; Thomas Czypionka; Uga Dumpis; Enrico Glaab; Eva Grill; Claudia Hanson; Pirta Hotulainen; Peter Klimek; Mirjam Kretzschmar; Tyll Krüger; Jenny Krutzinna; Nicola Low; Helena Machado; Carlos Martins; Martin McKee; Sebastian Bernd Mohr; Armin Nassehi; Matjaž Perc; Elena Petelos; Martyn Pickersgill; Barbara Prainsack; Joacim Rocklöv; Eva Schernhammer; Anthony Staines; Ewa Szczurek; Sotirios Tsiodras; Steven Van Gucht; Peter Willeit
Journal:  Lancet Reg Health Eur       Date:  2021-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.